Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Curis, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
CRIS
Nasdaq
2836
www.curis.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Curis, Inc.
Curis, Inc. Q1 2026 Earnings Call Summary
- May 13th, 2026 6:30 am
Curis Inc (CRIS) Q1 2026 Earnings Call Highlights: Progress in Lymphoma Study and Financial ...
- May 12th, 2026 11:02 pm
Curis Provides First Quarter 2026 Business Update
- May 12th, 2026 2:00 pm
Vericel Corporation (VCEL) Reports Q1 Loss, Beats Revenue Estimates
- May 7th, 2026 9:15 am
Curis to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on May 12, 2026
- May 5th, 2026 3:11 pm
Kiniksa Pharmaceuticals International, plc (KNSA) Tops Q1 Earnings and Revenue Estimates
- Apr 28th, 2026 6:45 am
Curis (CRIS) Upgraded to Buy: What Does It Mean for the Stock?
- Apr 15th, 2026 10:00 am
Curis Inc (CRIS) Q4 2025 Earnings Call Highlights: A Turnaround with Strong Quarterly Profit ...
- Mar 19th, 2026 9:02 pm
Curis, Inc. Q4 2025 Earnings Call Summary
- Mar 19th, 2026 6:12 pm
Curis (CRIS) Q4 2025 Earnings Call Transcript
- Mar 19th, 2026 3:37 pm
Curis: Q4 Earnings Snapshot
- Mar 19th, 2026 2:11 pm
Curis Provides Fourth Quarter 2025 Business Update
- Mar 19th, 2026 2:00 pm
Curis to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on March 19, 2026
- Mar 12th, 2026 2:27 pm
How The Curis (CRIS) Narrative Is Evolving As Assumptions Shift But The Target Stays
- Mar 11th, 2026 11:12 am
How The Narrative Around Curis (CRIS) Is Shifting As Assumptions Change Not The US$14 Target
- Feb 10th, 2026 7:08 pm
Looking At The Narrative For Curis CRIS After Fresh Funding And Fair Value Reset
- Jan 11th, 2026 11:08 am
Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds
- Jan 9th, 2026 6:00 am
Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds
- Jan 7th, 2026 6:45 am
Curis Provides Updated Data from its Frontline AML Triplet Study
- Dec 9th, 2025 6:00 am
How Recent Developments Are Shaping the Curis Investment Story
- Nov 28th, 2025 3:08 am
Scroll